Biogen 3rd-qtr beats consensus forecasts

25 October 2022
biogen_big

US biotech major Biogen (Nasdaq: BIIB) today reported third quarter 2022 financial results that were better than investors expected, but the stock fell 2.3% to $267.84 in early trading.

Third quarter total revenue of $2.51 billion decreased 10% versus the prior year at actual currency and 8% at constant currency, but exceeded consensus estimates of $2.47 billion.

Third quarter generally accepted accounting principles (GAAP) net income and diluted earnings per share (EPS) attributable to Biogen were $1.14 billion and $7.84, respectively. Third quarter non-GAAP net income and diluted EPS attributable to Biogen were $691 million and $4.77, respectively. The latter figure exceeded expectations of $4.13 per share.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology